We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

A new study validated the use of tumor markers to select chemotherapy drugs for patients with metastatic pancreatic cancer (Photo courtesy of SPL).

Study Results Validate Use of Tumor Markers to Treat Metastatic Cancer

 Promising results obtained in a recently conducted pilot study demonstrated the feasibility of using molecular tumor markers as the basis for selecting the chemotherapeutic agents to use in patients with metastatic pancreatic cancer. More...
17 Jun 2019
In this photomicrograph, the brown areas were stained for a biomarker in tissue from a patient who developed pancreatic cancer from a cyst (Photo courtesy of Dr. Koushik Das, Washington University).

Immunodiagnostic Test Predicts Progression of Pancreatic Cyst to Cancer

 By using an immunodiagnostic test to detect the Das-1 antibody biomarker in fluid from pancreatic cysts, researchers were able to identify those cysts that were likely to become cancerous with 95% accuracy. More...
17 Jun 2019
Image: The NimbleGen MS 200 CGH LOH microarray detection scanner (Photo courtesy of Roche).

Kidney Transplant Rejection Linked to New Mismatch Locus

Approximately 20% of the kidney waiting list in the USA consists of candidates whose allografts have failed. Acute rejection is one of the strongest predictors of decreased allograft survival. More...
13 Jun 2019
Image: The NimbleGen MS 200 CGH LOH microarray detection scanner (Photo courtesy of Roche).

Kidney Transplant Rejection Linked to New Mismatch Locus

Approximately 20% of the kidney waiting list in the USA consists of candidates whose allografts have failed. Acute rejection is one of the strongest predictors of decreased allograft survival. More...
13 Jun 2019
Image: The SLAN-96 real-time polymerase chain reaction (PCR) instrument (Photo courtesy of QuanDx/Zeesan Biotech).

Unexpected Prevalence of High-Risk HPV Types Demonstrated

Low- and middle-income countries have high incidences of cervical cancer linked to human papillomavirus (HPV), and without resources for cancer screenings these countries bear 85% of all cervical cancer cases. More...
13 Jun 2019
Image: The SLAN-96 real-time polymerase chain reaction (PCR) instrument (Photo courtesy of QuanDx/Zeesan Biotech).

Unexpected Prevalence of High-Risk HPV Types Demonstrated

Low- and middle-income countries have high incidences of cervical cancer linked to human papillomavirus (HPV), and without resources for cancer screenings these countries bear 85% of all cervical cancer cases. More...
13 Jun 2019
Image: The nCounter Max analysis system (Photo courtesy of NanoString Technologies).

Custom NanoString Assay Detects Bowel Cancer Subtypes

Colorectal cancer (CRC) is the fourth leading cause of cancer-related deaths worldwide. The median overall survival of metastatic (m)CRC patients with unresectable disease remains around 24 months with standard chemotherapies. More...
13 Jun 2019
GLOBETECH PUBLISHING LLC